Mr. Tetsuomi Takano, President and CEO, t2T Healthcare Inc., was invited by China Pharmaceutical Innovation and Research Development Association (PhIRDA) to “2025 Pharmaceutical Innovation Policy Forum”, which was held at Shanghai Platinum Hanjue Hotel on Sat, 24 May 2025.

He made a keynote lecture titled “Current Status of Pharmaceutical Regulations and Clinical Development in Japan: Government-Industry-Academia’s Collaborative Efforts to Eliminate Drug Loss & Drug Lag” to Chinese pharmaceutical and related companies with the co-speakers of Mr. Yoshitaka Kusabiraki (Chair, Industry Development Sub Committee, Pharmaceutical Industrial Policy Committee, JPMA) and Dr. Sammy Jiang (Chairperson and CEO, Boan Biotechnology Co., Ltd.) at the China-Japan Joint Session.

In recent years, Chinese pharmaceutical companies have rapidly increased their presence in Japan.  t2T Healthcare Inc. anticipates a significant increase in the number of foreign pharmaceutical companies conducting clinical studies and launching products in Japan within the next few years.